Dimethyl sulfoxide attenuates TNF-α-induced production of MMP-9 in human keratinocytes

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 74, Issue 20, 2011, Pages 1319-1322

  Majtan, Juraj ^a,b   Majtan, Viktor ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; GELATINASE B; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DOWN REGULATION; ENZYME INHIBITION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INFLAMMATION; ZYMOGRAPHY;

CELLS, CULTURED; DIMETHYL SULFOXIDE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION; KERATINOCYTES; MATRIX METALLOPROTEINASE 9; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 80052666920     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2011.600661     Document Type: Article

References (12)

1. Bertelli, G., Gozza, A., Forno, G. B., Vidili, M. G., Silvestro, S., Venturini, M., Del Mastro, L., Garrone, O., Rosso, R., and Dini, D. 1995. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: A prospective clinical study. J. Clin. Oncol. 13:2851-55.
2. Chakraborti, S., Mandal, M., Das, S., Mandal, A., and Chakraborti, T. 2003. Regulation of matrix metalloproteinases: An overview. Mol. Cell. Biochem. 253:269-85.
3. Duimel-Peeters, I. G. P., Houwing, R. H., Teunissen, C. P., Berger, M. P. F., Snoeckx, L. H. E. H., and Halfens, R. J. G. 2003. A systematic review on the eficaccy of topical skin application of dimethyl sulfoxide on wound healing and as an anti-inflammatory drug. Wounds 15:361-70. (Pubitemid 37524286)
4. Ekekezie, I. I., Thibeault, D. W., Simon, S. D. N., M, Merrill, J. D., Ballard, R. A., Ballard, P. L., and Truoug, W. E. 2004. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics 113:1709-14. (Pubitemid 38697980)
5. Han, Y. P., Nien, Y. D., and Garner, W. L. 2002. Tumor necrosis factor-alphainduced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase. J. Biol. Chem. 277:27319-27. (Pubitemid 34951751)
6. Kelly, K. A., Hill, M. R., Youkhana, K., Wanker, F., and Gimble, J. M. 1994. Dimethyl sulfoxide modulates NF-kB and cytokine activation in lipopolysaccharide-treated murine macrophages. Infect. Immun. 62:3122-28. (Pubitemid 24232091)
7. Kleiner, D., and Stetler-Stevenson, W. 1994. Quantitative zymography: Detection of pictogram quantities of gelatinases. Anal. Biochem. 218:325-29. (Pubitemid 24141631)
8. Moor, A. N., Vachon, D. J., and Gould, L. J. 2009. Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers. Wound Repair Regen. 17:832-39.
9. Rayment, E. A., Upton, Z., and Shooter, G. K. 2008. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluids is related to the clinical severity of the ulcer. Br. J. Dermatol. 158:951-61. (Pubitemid 351521431)
10. Reiss, M. J., Han, Y. P., Garcia, E., Goldberg, M., Yu, H., and Garner, W. L. 2010. Matrix metalloproteinase-9 delays wound healing in a murine wound model. Surgery 147:295-302.
11. Santos, N. C., Figueira-Coelho, J., Martins-Silva, J., and Saldanha, C. 2003. Multidisciplinary utilization of dimethyl sulfoxide: Pharmacological, cellular, and molecular aspects. Biochem. Pharmacol. 65:1034-41.
12. Woessner, J. F. 2002. MMPs and TIMPs - An historical perspective. Mol. Biotechnol. 22:33-49.